Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma
暂无分享，去创建一个
[1] Y. Hirasawa,et al. Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas. , 1999, Cancer letters.
[2] P. Leung,et al. Assessment of chemosensitivity in patients with osteogenic sarcoma using the doxorubicin binding assay , 1998, Journal of surgical oncology.
[3] Y. Hirasawa,et al. Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma , 1998, Cancer.
[4] T. Grogan,et al. P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy. , 1997, Journal of the National Cancer Institute.
[5] A. Colacci,et al. Multidrug resistance and malignancy in human osteosarcoma. , 1996, Cancer research.
[6] P. Picci,et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. , 1995, The New England journal of medicine.
[7] A. Huvos. Bone tumors, diagnosis, treatment, and prognosis , 1979 .